Background Systemic immune‐inflammation index (SII) is a novel inflammatory marker
based on neutrophils, platelets and lymphocytes counts, which has potential prognostic …

Objective Systemic immune-inflammation index (SII), derived from blood cell counts of
circulating platelets, neutrophils, and lymphocytes, has been identified as a novel …

Background This study examines the predictive value of a novel systemic immune‐
inflammation index (SII, platelet× neutrophil/lymphocyte ratio) in coronary artery disease …

Background The systemic immune-inflammation index (SII; neutrophil× platelet/lymphocyte)
is a novel marker for immune and inflammatory status and is associated with adverse …

Background Inflammation has been linked to the development of coronary heart disease
(CHD). The systemic immune inflammation index (SII) is a useful biomarker of systemic …

Systemic immune-inflammation index (SII; platelet count× neutrophil-to-lymphocyte ratio), a
novel marker, predicts adverse clinical outcomes in coronary artery diseases (CAD). We …

Objective Prognostic indicators in acute coronary syndrome (ACS) would aid in decision-
making and identifying high-risk patients. The systemic immune-inflammation index (SII) has …

Background Several studies have investigated the value of the systemic immune-
inflammation index (SII) for predicting cardiovascular disease (CVD), but the results were …

Background Atherosclerosis is a process that causes coronary artery disease and is
associated with the inflammatory response. In this study, we aimed to evaluate the …

Background It is well-known that systemic inflammation plays a crucial role in the
pathogenesis and prognosis of acute myocardial infarction (AMI). The systemic immune …